Fulgent Genetics Q3 Adj. EPS $(0.09) Beats $(0.65) Estimate, Sales $90.412M Beat $86.300M Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Beats
Fulgent Genetics (NASDAQ:FLGT) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.65) by 86.15 percent. This is a 164.29 percent decrease over earnings of $0.14 per share
Fulgent Genetics (NASDAQ:FLGT) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.65) by 86.15 percent. This is a 164.29 percent decrease over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $90.412 million which beat the analyst consensus estimate of $86.300 million by 4.76 percent. This is a 7.54 percent increase over sales of $84.069 million the same period last year.